This bidirectional effect, with overactivation driving vascular remodeling and deficiency leading to emphysematous destruction, supports HIF-2α as a molecular “switch” between vascular-dominant and airway/emphysema-dominant trajectories in COPD [110]. Here, EPAS1 is linked to chronic obstructive pulmonary disease.